Literature DB >> 1054518

Studies on the primary structure of the influenza virus hemagglutinin.

J J Skehel, M D Waterfield.   

Abstract

The amino-terminal sequence and composition of the subunits of the hemagglutinin (HA) of influenza virus has been determined. The hemagglutinin has been isolated by two techniques. (1) as the intact hemagglutinin after disruption of the virus in sodium dodecyl sulfate, giving 2 subunits of 58,000 daltons (HA1) and 26,000 daltons (HA2), and (2) after treatment of the virus with bromelain, giving 2 subunits of 58,000 daltons (BHA1) and 21,000 daltons (BHA2). In both preparations these subunits are linked by disulfide bonds. The aminoterminal sequences of HA1 and BHA1, and HA2 and BHA2 are the same. The composition of the 50 residue peptide associated with the membrane, which is removed from the C-terminus of HA2 by bromelain, is deduced and shown to be hydrophobic and contain 50% of the serine residues of HA2. The biosynthetic precursor of the hemagglutinin has been purified from the membranes of abortively infected chick fibroblasts and shown to have the same amino terminus as HA1. Thus the order of biosynthesis is NH2-HA1-HA2-COOH. The amino-terminal sequence of BHA2--at the cleavage site of the precursor--is shown to be a palindrome: NH2-Gly-Leu-Phe-Gly-Ala-Ile-Ala-Gly-Phe-Ile-. This sequence is conserved in representative viruses from each of the major pandemics. A region of homologous sequence is described between the hemagglutinins of influenza type A and B viruses.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1054518      PMCID: PMC432247          DOI: 10.1073/pnas.72.1.93

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  STRUCTURAL STUDIES ON THE PROTEIN SUBUNITS FROM THREE STRAINS OF INFLUENZA VIRUS.

Authors:  W G LAVER
Journal:  J Mol Biol       Date:  1964-07       Impact factor: 5.469

2.  The sequence of amino acid residues in bovine pancreatic ribonuclease: revisions and confirmations.

Authors:  D G SMYTH; W H STEIN; S MOORE
Journal:  J Biol Chem       Date:  1963-01       Impact factor: 5.157

3.  Studies on the formation of the influenza virus envelope.

Authors:  A J Hay
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

4.  Advances in the gas chromatographic analysis of amino acid phenyl- and methylthiohydantoins.

Authors:  J J Pisano; T J Bronzert; H B Brewer
Journal:  Anal Biochem       Date:  1972-01       Impact factor: 3.365

5.  Quantitative procedures for use with the Edman-Begg sequenator. Partial sequences of two unusual immunoglobulin light chains, Rzf and Sac.

Authors:  O Smithies; D Gibson; E M Fanning; R M Goodfliesh; J G Gilman; D L Ballantyne
Journal:  Biochemistry       Date:  1971-12-21       Impact factor: 3.162

6.  Separation of two polypeptide chains from the hemagglutinin subunit of influenza virus.

Authors:  W G Laver
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

7.  Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes.

Authors:  S G Lazarowitz; R W Compans; P W Choppin
Journal:  Virology       Date:  1971-12       Impact factor: 3.616

8.  Palindromes in chromosomes.

Authors:  D A Wilson; C A Thomas
Journal:  J Mol Biol       Date:  1974-03-25       Impact factor: 5.469

9.  The polypeptide composition of influenza A viruses.

Authors:  J J Skehel; G C Schild
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

10.  A protein sequenator.

Authors:  P Edman; G Begg
Journal:  Eur J Biochem       Date:  1967-03
View more
  76 in total

1.  N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil.

Authors:  J Chen; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation.

Authors:  M J Gething; J M White; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers.

Authors:  C Gray; S A Tatulian; S A Wharton; L K Tamm
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

4.  Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.

Authors:  F M Gotch; C Kelly; S A Ellis; L Wallace; A B Rickinson; J van der Poel; M J Crumpton; A J McMichael
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

Review 5.  Targeting B cell responses in universal influenza vaccine design.

Authors:  Kaval Kaur; Meghan Sullivan; Patrick C Wilson
Journal:  Trends Immunol       Date:  2011-09-21       Impact factor: 16.687

6.  Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases.

Authors:  Oleg P Zhirnov; Mine R Ikizler; Peter F Wright
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Proteins of the kidney microvillar membrane. The amphipathic form of dipeptidyl peptidase IV.

Authors:  D C Macnair; A J Kenny
Journal:  Biochem J       Date:  1979-05-01       Impact factor: 3.857

8.  Cellular changes in lungs of mice infected with influenza virus: characterization of the cytotoxic responses.

Authors:  P R Wyde; T R Cate
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

9.  Rat brain Thy-1 glycoprotein. The amino acid sequence, disulphide bonds and an unusual hydrophobic region.

Authors:  D G Campbell; J Gagnon; K B Reid; A F Williams
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

10.  Structure of bromelain-released influenza virus haemagglutinin as revealed by electrophoresis, sedimentation and electron microscopy.

Authors:  M S Siniakov; I G Kharitonenkov; V B Grigorjev
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.